Walbert Keli

CIK 00020514892 companiesSOUTH SAN FRANCISCO, CA

Transactions

Companies

Filings

CIK

0002051489

Recent Transactions

12 trades

Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2026-05-21+1,700→ 1,700 total
Disposition from Tender
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−17,051→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−15,388→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−664→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−7,297→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−14,684→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−8,332→ 0 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2026-01-01+14,684→ 14,684 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-01+7,961→ 17,051 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2025-12-11+3,400→ 3,400 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-08+9,090→ 9,090 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2025-01-08$33.00/sh+15,388→ 15,388 total

C/O SPRUCE BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 740

SOUTH SAN FRANCISCO, CA, 94080